Moreover, they cover genes previously implicated in PD relevant phenotypes such as dementia (CXCR4) and neurodegeneration (MAPK1) (see Discussion section for details on prior functional implications of these genes in PD and molecular sex differences). This evidence concerns the gene MAPK1 and Parkinson disease.